Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-FR Version v5-EN
Language French English
Date Updated 2020-10-23 2020-10-23
Drug Identification Number 02408163 02408163
Brand name FIBRISTAL FIBRISTAL
Common or Proper name ulipristal acetate ulipristal acetate
Company Name ALLERGAN INC ALLERGAN INC
Ingredients ULIPRISTAL ACETATE ULIPRISTAL ACETATE
Strength(s) 5MG 5MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 30 tablets 30 tablets
ATC code G03XB G03XB
ATC description OTHER SEX HORM. & MODULATORS OF THE GENITAL SYSTEM OTHER SEX HORM. & MODULATORS OF THE GENITAL SYSTEM
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date
Actual start date 2020-09-24 2020-09-24
Estimated end date
Actual end date 2020-09-24 2020-09-24
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments Product recall Product recall
Health Canada comments